We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize ...

If you are wondering whether Becton Dickinson is starting to look like good value, you are not alone. This article will help you frame that question clearly. The stock last closed at US$177.38, with a ...

Becton, Dickinson and Company has lagged behind the broader market over the past year, yet analysts remain somewhat optimistic about the stock’s prospects.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Becton Dickinson (NYSE:BDX) has introduced the BD Vacutainer Urine Complete Cup Kit, aimed at improving urine specimen ...

Becton Dickinson (NYSE:BDX) has completed the spin-off of its Biosciences and Diagnostic Solutions businesses, which are being merged with Waters Corporation. The company has launched a $2 billion ...

Becton Dickinson (NYSE:BDX) shares dropped nearly 3% in premarket trading on Monday after the medical technology group posted better-than-expected first-quarter results but issued full-year guidance ...

The Invesco Growth and Income Fund outperformed its benchmark in Q4 2025, led by industrials and health care. Read the full analysis for more details.

Hologic HOLX posted Diagnostics revenues of $464.4 million in the first quarter of fiscal 2026, down 1.3% from last year. The segment remains anchored by the molecular diagnostic assays, which run ...

Irvine medical device maker Masimo has entered an agreement to be acquired by Danaher, owner of Brea-based Beckman Coulter, in a $9.9 billion deal.

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index moved to the “Neutral” zone on Monday. U.S. stocks settled mostly higher on Monday, with ...